December 11, 2025 | Pharmaphorum
Discover Jim Sage’s insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum “12 Questions” interview.

We’re pleased to share that Jim Sage, Global CEO and President of Inizio Engage, has been featured in pharmaphorum’s latest “12 Questions” interview series.
In the conversation, Jim reflects on his career across international markets, his motivations as a leader, and the experiences that have shaped his approach to building high-performing teams. He also explores some of the most pressing challenges facing the pharmaceutical industry today, including pricing pressures, launch performance, and the need for new reimbursement models.
Jim highlights how data, technology, and AI are already transforming the way organisations operate, and discusses the growing importance of patient-centric approaches, from HUB services to personalised support throughout the treatment journey.
This content was provided by Inizio
Latest Content from Inizio
Overview of spondyloarthritis patient profiles and treatment pathways.
How study design which reflects doctors’ real world choices can optimise results.
Using in-depth-interviews as well as a SmartPhone app to collect real patient cases from physicians to find out opportunity for a new product.
Published in eyeforpharma July 29 by Rachel Howard
HCPs predict the future of the biologics market
What do you know about chaos theory?
Published in pharmaphorum July 2015 by Julie Denny
Published in eyeforpharma June 9 by Rachel Howard and Raquel Nunez.
An introduction to the HCV LATAM patient.
Published in eyeforpharma 20 May by Rachel Howard
